Demand pull is outrunning the plan for one still-small offering, and the company is visibly re-pointing itself at it
The model's full reasoning — Q1 2017 call → NOWe need to determine if management describes an offering with both: (1) customer response running ahead of what company prepared for, and (2) company responding now by putting more behind it. The offering must be small relative to total business. Scan transcript for such descriptions. Look for mentions of demand exceeding expectations, capacity, supply, etc., and concrete steps to expand. Possible candidates: Cepheid? But Cepheid is a large acquisition, not small. Pall? No. The question asks for an identifiable offering that is still a clearly smaller part of company's overall results today. Look for something like a new product or initiative. For example, the Biomek i-Series launch? But no mention of demand exceeding preparation. The CM130 coring monitoring system? No. The Xpert Xpress flu/RSV test? No. Maybe the AVT acquisition? That's an acquisition, not an offering with demand ahead. Check for phrases like "ahead of" or "exceeded" or "more than we expected" etc. In the transcript, Tom Joyce says: "Cepheid is off to a great start and achieved double-digit core revenue growth in the quarter." But that's not about demand ahead of preparation. Look at the discussion about Cepheid's omni platform: "We're very confident in the potential of that platform. I think realistically, there were couple of things that we wanted the team to sure up, technically around that product and couple of things that we wanted to make sure were in place commercially as well. And so right now, we're looking at probably the first, early part of next year, maybe even as early as first quarter next year for that launch, just to make sure that we have that in the best shape possible." That's about future launch, not current demand ahead. What about the Dental business? No. Maybe the "single use technologies" at Pall? No. The question asks for an offering that is still small relative to total business. Could be something like the "Biomek i-Series" but no demand ahead. Look for any mention of "exceeded" or "ahead" in context of customer response. For example, "We saw signs of stabilization across a number of our industrial and process end-markets. We were also encouraged by strong bookings throughout the quarter." That's not specific. Perhaps the "CM130 coring monitoring system" - but no mention of demand. Maybe the "Xpert Xpress" test - but no.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
HCKT · Q1 2024 → YESThe question is about whether management describes one identifiable offering that's still small, where customer response is ahead of what they prepared for, AND they're responding now by putting more ...YES The transcript describes AI Explorer (the GenAI assessment platform) as a small, early-stage offering (nominal Q1 revenue impact, part of broader GenAI pivot). Management states customer response is exceeding preparation: "over 175 demo meetings with many more scheduled... resulted in a number of new enterprise...
SYY · Q1 2023 → YESThe question is about whether management describes one identifiable offering or initiative that's still a smaller part of the business, where customer response is running ahead of what they prepared f...YES The transcript shows that Sysco Your Way is presented as a smaller, still-developing offering (described as part of the Recipe For Growth pillars, with its scale expected to grow each quarter and currently limited to specific neighborhoods and recent international rollouts like Toronto and Dublin).
PRPH · Q1 2023 → YESThe question asks if management describes one identifiable offering that's still a smaller part of the business, where customer response is running ahead of what they prepared for, AND they're respond...YES The lozenge manufacturing facility is the clearest match. It is explicitly described as “the least interesting business we’re developing” and still a smaller slice of overall results (COVID testing was the dominant revenue driver for the prior two years).